| Gary P Anzalone, MD | |
|
208 Thompson Ave, El Dorado, AR 71730-5756 | |
| (870) 862-1351 | |
| (870) 862-2815 |
| Full Name | Gary P Anzalone |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 35 Years |
| Location | 208 Thompson Ave, El Dorado, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710937529 | NPI | - | NPPES |
| 5J135 | Other | AR | MEDICARE LEGACY NUMBER |
| 123460001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | R-4500 (Arkansas) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | R-4500 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical Center Of South Arkansas | El dorado, AR | Hospital |
| Ouachita County Medical Center | Camden, AR | Hospital |
| Entity Name | Associated Pathologists Laboratory Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033168489 PECOS PAC ID: 9830164755 Enrollment ID: O20040907000674 |
News Archive
The University of Kansas Cancer Center's Cancer Control and Population Health program got a boost in April when Won Choi, Ph.D., and his colleagues were awarded a $2.7 million, five-year NCI grant to create an Internet-based program to help American Indian tribal college students stop smoking.
Asklepion Pharmaceuticals, LLC. today announced that the U.S. Food and Drug Administration (FDA) approved CHOLBAM (cholic acid) as a once-daily treatment for cholic acid deficiency in bile acid synthesis disorders due to single enzyme defects.
Former President Jimmy Carter is traveling to Haiti and the Dominican Republic in hopes of encouraging the country "leaders to forge a pact to rid the island of Hispaniola of malaria," the Associated Press/Los Angeles Times reports.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary P Anzalone, MD 208 Thompson Ave, El Dorado, AR 71730-5756 Ph: (870) 862-1351 | Gary P Anzalone, MD 208 Thompson Ave, El Dorado, AR 71730-5756 Ph: (870) 862-1351 |
News Archive
The University of Kansas Cancer Center's Cancer Control and Population Health program got a boost in April when Won Choi, Ph.D., and his colleagues were awarded a $2.7 million, five-year NCI grant to create an Internet-based program to help American Indian tribal college students stop smoking.
Asklepion Pharmaceuticals, LLC. today announced that the U.S. Food and Drug Administration (FDA) approved CHOLBAM (cholic acid) as a once-daily treatment for cholic acid deficiency in bile acid synthesis disorders due to single enzyme defects.
Former President Jimmy Carter is traveling to Haiti and the Dominican Republic in hopes of encouraging the country "leaders to forge a pact to rid the island of Hispaniola of malaria," the Associated Press/Los Angeles Times reports.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 9 days ago